Rockefeller Capital Management
TENX icon

Rockefeller Capital Management’s Tenax Therapeutics TENX Stock Holding History

Rockefeller Capital Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40K Buy
2,501
+2,500
+250,000% +$33.8K ﹤0.01% 3393
2025
Q4 		$12 Sell
1
-1
-50% -$9 ﹤0.01% 4658
2025
Q3 		$15 Buy
+2
New +$12 ﹤0.01% 4411

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Rockefeller Capital Management's TENX Position: Q1 2026 in Review

Rockefeller Capital Management increased its Tenax Therapeutics (TENX) stake by 250,000% in Q1 2026, buying an estimated $33.8K and bringing the position to 2,501 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Rockefeller Capital Management first reported a position in TENX in Q3 2025 and has held it in 3 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Rockefeller Capital Management held 2,501 shares of Tenax Therapeutics worth $40K as of Q1 2026.
  • Rockefeller Capital Management bought 2,500 Tenax Therapeutics shares in Q1 2026, an estimated $33.8K.
  • Tenax Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3393 holding.
  • Rockefeller Capital Management first reported a position in Tenax Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.